IGF-I treatment of patients with Laron syndrome suppresses serum thrombopoietin levels but does not affect serum erythropoietin

被引：0

作者：

Shevah, Orit ^{[1
]}

Yacobovich, Joanne ^{[2
]}

Zoldan, Meira ^{[2
]}

Tamary, Hannah ^{[2
]}

Laron, Zvi ^{[1
]}

机构：

[1] Tel Aviv Univ, Sackler Fac Med, Schneider Childrens Med Ctr, Endocrinol & Diabet Res Unit, IL-49100 Petah Tiqwa, Israel

[2] Tel Aviv Univ, Sackler Fac Med, Schneider Childrens Med Ctr, Div Hematol Oncol, IL-49100 Petah Tiqwa, Israel

来源：

AMERICAN JOURNAL OF HEMATOLOGY | 2009年 / 84卷 / 01期

关键词：

GROWTH-FACTOR-I; HORMONE;

D O I：

10.1002/ajh.21318

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：64 / 64

页数：1

共 36 条

[31] Serum but not cerebrospinal fluid levels of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 (IGFBP-3) are increased in Alzheimer's disease [J].

Johansson, Per ;

Aberg, Daniel ;

Johansson, Jan-Ove ;

Mattsson, Niklas ;

Hansson, Oskar ;

Ahren, Bo ;

Isgaard, Jorgen ;

Aberg, N. David ;

Blennow, Kaj ;

Zetterberg, Henrik ;

Wallin, Anders ;

Svensson, Johan .

PSYCHONEUROENDOCRINOLOGY, 2013, 38 (09) :1729-1737

[32] Serum levels of IGF-I, IGFBP-3 and colorectal cancer risk: results from the EPIC cohort, plus a meta-analysis of prospective studies [J].

Rinaldi, Sabina ;

Cleveland, Rebecca ;

Norat, Teresa ;

Biessy, Carine ;

Rohrmann, Sabine ;

Linseisen, Jakob ;

Boeing, Heiner ;

Pischon, Tobias ;

Panico, Salvatore ;

Agnoli, Claudia ;

Palli, Domenico ;

Tumino, Rosario ;

Vineis, Paolo ;

Peeters, Petra H. M. ;

van Gils, Carla H. ;

Bueno-de-Mesquita, Bas H. ;

Vrieling, Alina ;

Allen, Naomi E. ;

Roddam, Andrew ;

Bingham, Sheila ;

Khaw, Kay-Tee ;

Manjer, Jonas ;

Borgquist, Signe ;

Dumeaux, Vanessa ;

Gram, Inger Torhild ;

Lund, Eiliv ;

Trichopoulou, Antonia ;

Makrygiannis, Georgios ;

Benetou, Vassiliki ;

Molina, Esther ;

Donate Suarez, Ignacio ;

Barricarte Gurrea, Aurelio ;

Gonzalez, Carlos A. ;

Tormo, Maria-Jose ;

Altzibar, Jone M. ;

Olsen, Anja ;

Tjonneland, Anne ;

Gronbaek, Henning ;

Overvad, Kim ;

Clavel-Chapelon, Francoise ;

Boutron-Ruault, Marie-Christine ;

Morois, Sophie ;

Slimani, Nadia ;

Boffetta, Paolo ;

Jenab, Mazda ;

Riboli, Elio ;

Kaaks, Rudolf .

INTERNATIONAL JOURNAL OF CANCER, 2010, 126 (07) :1702-1715

[33] Serum insulin-like growth factor-I (IGF-I) reference ranges for chemiluminescence assay in childhood and adolescence. Data from a population of in- and out-patients [J].

Bedogni, G. ;

Giannone, G. ;

Maghnie, M. ;

Giacomozzi, C. ;

Di Iorgi, N. ;

Pedicelli, S. ;

Peschiaroli, E. ;

Melioli, G. ;

Muraca, M. ;

Cappa, M. ;

Cianfarani, S. .

GROWTH HORMONE & IGF RESEARCH, 2012, 22 (3-4) :134-138

[34] Inhibition of proliferation of PC-3 human prostate cancer by antagonists of growth hormone-releasing hormone: Lack of correlation with the levels of serum IGF-I and expression of tumoral IGF-II and vascular endothelial growth [J].

Plonowski, A ;

Schally, AV ;

Letsch, M ;

Krupa, M ;

Hebert, F ;

Busto, R ;

Groot, K ;

Varga, JL .

PROSTATE, 2002, 52 (03) :173-182

[35] Assessing the Impact of Insulin Glargine and Detemir Treatment to Serum Total IGF1 Levels in the Insulin-Naive Type 2 Diabetic Patients [J].

Cander, Soner ;

Gul, Ozen Oz ;

Dizdar, Oguzhan Sitki ;

Koca, Nizameddin ;

Aydin, Taner ;

Sarandol, Emre ;

Ersoy, Canan .

METABOLIC SYNDROME AND RELATED DISORDERS, 2017, 15 (05) :220-225

[36] The Influence of Promoter -202 A/C Polymorphism (rs2854744) of the IGFBP-3 Gene on Erectile Dysfunction Risk and Serum Levels of IGF-I and IGFBP-3 (Publication with Expression of Concern) [J].

Safarinejad, Mohammad Reza ;

Shafiei, Nayyer ;

Safarinejad, Shiva .

JOURNAL OF UROLOGY, 2013, 189 (01) :374-379

← 1 2 3 4 →